tetradecanoylphorbol acetate has been researched along with Acute Relapsing Multiple Sclerosis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hestvik, AL; Holmøy, T; Høglund, RA; Maghazachi, AA | 1 |
Gata, JM; Izquierdo, G; Lucas, M; Rodríguez, MC; Solano, F; Zayas, MD | 1 |
2 other study(ies) available for tetradecanoylphorbol acetate and Acute Relapsing Multiple Sclerosis
Article | Year |
---|---|
Expression and functional activity of chemokine receptors in glatiramer acetate-specific T cells isolated from multiple sclerosis patient receiving the drug glatiramer acetate.
Topics: Adult; Blood; CD4-Positive T-Lymphocytes; Cell Movement; Cells, Cultured; Cerebrospinal Fluid; Chemokines; Chemotaxis, Leukocyte; Flow Cytometry; Gene Expression; Glatiramer Acetate; Humans; Inflammation; Ionomycin; Lymphocyte Activation; Male; Multiple Sclerosis, Relapsing-Remitting; Peptides; Receptors, CCR4; Receptors, CCR5; Receptors, CCR6; Receptors, CXCR3; Signal Transduction; Tetradecanoylphorbol Acetate | 2011 |
Regulation by interferon beta-1a of reactive oxygen metabolites production by lymphocytes and monocytes and serum sulfhydryls in relapsing multiple sclerosis patients.
Topics: Adult; Dithionitrobenzoic Acid; Female; Free Radicals; Humans; Interferon beta-1a; Interferon-beta; Lymphocytes; Male; Middle Aged; Monocytes; Multiple Sclerosis, Relapsing-Remitting; Oxidation-Reduction; Reactive Oxygen Species; Sulfhydryl Compounds; Tetradecanoylphorbol Acetate | 2003 |